Arcoma AB Asset Resilience Ratio

Latest as of March 2016: 18.92%

Arcoma AB asset resilience ratio. Arcoma AB (ARCOMA) has an Asset Resilience Ratio of 18.92% as of March 2016. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Arcoma AB to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Skr14.41 Million
≈ $1.55 Million USD Cash + Short-term Investments

Total Assets

Skr76.19 Million
≈ $8.20 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio of Arcoma AB (None–None)

Asset resilience ratio of Arcoma AB from None to None. This chart shows how Arcoma AB's Asset Resilience Ratio has changed over time. Read debt load of Arcoma AB for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Arcoma AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ARCOMA total asset value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr0.00 0%
Short-term Investments Skr14.41 Million 18.92%
Total Liquid Assets Skr14.41 Million 18.92%

Asset Resilience Insights

  • Good Liquidity Position: Arcoma AB maintains a healthy 18.92% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Arcoma AB Industry Peers by Asset Resilience Ratio

Compare Arcoma AB's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Applied BioCode
TW:6598
Medical Devices 9.75%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Radiant Innovation
TWO:3373
Medical Devices 0.82%
Impedimed Ltd
AU:IPD
Medical Devices 46.15%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%

Arcoma AB Asset Resilience Ratio by Year (None–None)

Arcoma AB asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for Arcoma AB.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points

About Arcoma AB

ST:ARCOMA Sweden Medical Devices
Market Cap
$12.32 Million
Skr114.47 Million SEK
Market Cap Rank
#26367 Global
#546 in Sweden
Share Price
Skr8.00
Change (1 day)
-6.76%
52-Week Range
Skr6.92 - Skr9.80
All Time High
Skr25.60
About

Arcoma AB develops, produces, and provides radiology solutions and digital x-ray systems in Sweden and internationally. The company offers solutions for x-ray systems covering radiological applications and general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. It also provides x-ray detectors; video bank; and accessories for x-ray equipment comprising live camera, advanc… Read more